
Early Movers in Health AI Are Starting to Separate from the Pack
Issued on behalf of Avant Technologies Inc.
VANCOUVER – Baystreet.ca News Commentary – AI is rewriting the rules of healthcare —not in a burst, but in a careful, calculated march that balances innovation with caution. That same tension is playing out in statehouses like Connecticut's, where lawmakers are weighing how to regulate AI while also addressing the urgent needs of a strained healthcare workforce. Meanwhile, OpenAI just took its biggest step yet into health tech by releasing HealthBench, a benchmark dataset designed to test how well large language models can answer medical questions. Amid this flurry of policy, infrastructure, and research activity, several public companies are emerging as early leaders at the intersection of generative AI and healthcare—among them Avant Technologies, Inc. (OTCQB: AVAI), Amazon.com, Inc. (NASDAQ: AMZN), Royal Philips (NYSE: PHG), NVIDIA Corporation (NASDAQ: NVDA), and Oracle Corporation (NYSE: ORCL).
Analysts at MarketsandMarkets are forecasting the AI in Healthcare Market to surge at a massive 38.6% CAGR to an impressive US$110.61 billion by 2030. By 2035, Accenture analysts believe AI could add another $461 billion in value to a healthcare industry already on track to surpass $2.26 trillion.
Avant Technologies, Inc. (OTCQB: AVAI) is quietly but deliberately advancing its position in AI-powered healthcare through a proposed acquisition of its joint venture partner, Ainnova Tech. The two companies, already aligned under the Ai-nova Acquisition Corp. (AAC) banner, are now moving to unify operations—an intentional step that comes just ahead of their scheduled FDA pre-submission meeting this July. If completed, the merger would remove internal friction, streamline clinical trial planning, and strengthen their regulatory posture ahead of potential U.S. market entry.
'We believe bringing the two companies together will offer tremendous value for shareholders,' said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp. 'It will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally.'
At the core of this effort is Vision AI, a non-invasive clinical screening platform that combines retinal imaging, vital sign capture, and machine-learning algorithms to detect early signals of chronic illness—including diabetic retinopathy, cardiovascular disease, kidney and liver conditions, and type 2 diabetes. Operating under AAC, the joint venture holds global rights to the platform, which has shown more than 90% sensitivity in early detection, according to NIH -cited research.
"This milestone reflects our two-tiered strategy, rapid deployment in low-regulation markets where Vision AI operates as a screening tool, and simultaneous progress toward FDA clearance for the U.S. market,' said Vargas. 'Entering the U.S. will unlock significant commercial potential, and early engagement with regulators ensures we do so with speed, credibility, and a validated product."
Unlike many healthcare AI startups still stuck at concept stage, Avant's technology is already deployed in Latin America —including Chile, Mexico, and Brazil —where it's being tested in real-world clinical workflows. These field programs are not only helping build a safety and efficacy track record, they're also providing critical user feedback that shapes the platform's refinement and usability.
To support broader clinical reach, AAC recently integrated four new diagnostic algorithms into Vision AI. Trained on over 2.3 million clinical cases, these additions enhance the system's utility across a wider range of chronic conditions. With proven traction abroad and a pending regulatory milestone in the U.S., Avant is moving from potential to presence—and may soon find itself on the radar of a much larger healthcare conversation.
Amazon.com, Inc. (NASDAQ: AMZN) through AWS, is advancing real-world health applications of generative AI with tools like Health Kaki —a personalized AI companion developed for Singapore's Ministry of Health.
Powered by AWS Bedrock and Anthropic's Claude 3.5 Sonnet, Health Kaki delivers diet and exercise recommendations that align with cultural norms, clinical guidelines, and user preferences. Its success in moving from concept to production highlights AWS's role in building scalable, user-centric healthcare AI. With robust guardrails and modular architecture, AWS is positioning itself as a key infrastructure provider in the global shift toward 'well care.'
Royal Philips (NYSE: PHG) has partnered with NVIDIA Corporation (NASDAQ: NVDA) to co-develop a foundational AI model aimed at revolutionizing magnetic resonance (MR) imaging.
'Our AI-powered MRI solutions are already enabling healthcare providers to deliver better care to more people,' said Dr. Ioannis Panagiotelis, Business Leader of MRI at Philips. 'By partnering with NVIDIA to build an MR Foundational Model, we're pioneering a new frontier for medical imaging, one that has the potential to transform the role of MR in the diagnosis and treatment of a wide range of diseases. The benefits for patients and healthcare providers could be enormous.'
The initiative, announced at ISMRM 2025, will leverage NVIDIA's VISTA-3D and MAISI platforms to create a next-generation diagnostic tool that improves image quality, reduces scan times, and streamlines workflow. The AI-powered model will support features like zero-click scan planning, denoising, and real-time image preview, enhancing speed and accuracy for radiologists. This collaboration positions both companies at the forefront of AI-driven precision imaging, with broad implications for diagnostics and patient care.
Oracle Corporation (NYSE: ORCL) has expanded access to its Oracle Health Clinical AI Agent in Canada, bringing its generative AI-powered documentation assistant to a growing list of medical specialties.
"Time is our most precious, non-renewable resource," said Erin O'Halloran, vice president and Canada market leader, Oracle Health. ' Oracle Health Clinical AI Agent helps to restore the clinician-patient relationship, emphasize focused time with patients, and reduce clinician burnout. The availability of this solution marks another step toward modernizing the country's health information systems and providing a more digitally connected healthcare ecosystem."
The platform has already helped U.S. healthcare providers cut documentation time by 30%, freeing up clinicians to focus more on patient care. Integrated directly into Oracle's electronic health records system, the AI agent drafts notes, navigates patient histories, and suggests next steps in real time.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
CONTACT:
Baystreet.ca
cs@baystreet.ca
(250) 661-3391
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Baystreet.ca is a wholly-owned subsidiary of Baystreet.ca Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CTV News
34 minutes ago
- CTV News
Outbreak of forest tent caterpillars should last about 6 weeks
Experts say that in northeastern Ontario, the outbreak of forest tent caterpillars this year should last about six weeks. They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. Experts say we're in an outbreak. 'It's not as severe as it has been in the past,' said Dan Rowlinson, the provincial forest health field coordinator with the Ministry of Natural Resources. Caterpillar1 They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. (File) 'They're just in the tiny larval stage right now. So, they're just starting to feed on the aspen and the poplar trees. But they'll proceed through the summer and then we'll see more defoliation. I don't think it's going to be as significant as it was last year.' MNR monitoring shows eastern tent caterpillars are a problem, but Rowlinson said they're not as widespread as the forest tent species, also known as armyworms. Those are the ones experiencing the population boom. 'We're looking at about six weeks,' said Alexandra Binns, Science North's animal care technician, who said the area is on the upswing of a 10-year cycle. The last big outbreak was in 2018. 'Mice, rodents, but also birds and migratory birds, it's a quick and easy meal for them. And so as much as we might hate them, they are important to the environment.' — David Dutkiewicz, Invasive Species Centre 'Generally, once the young caterpillars emerge in early springtime, they can only really eat soft or freshly grown leaves,' Binns said. 'Because they can only eat those things, they eat them for about six weeks. That's the fresh start of spring. And then they'll start to cocoon and pupate from there.' Later in the summer, these pests will transform into moths. Caterpillar2 They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. (Photo from video) Despite their annoyance, experts agree that forest tent caterpillars are important to the ecological landscape. 'They are more nutrients for birds and things like that,' said David Dutkiewicz, an entomology technician with the Invasive Species Centre. 'Mice, rodents, but also birds and migratory birds, it's a quick and easy meal for them. And so as much as we might hate them, they are important to the environment.' Dutkiewicz said picking the forest tent caterpillars off trees and other greenery or wrapping tinfoil around the base of the tree. He said spraying them with soapy water will also work, but doing it too often could harm the tree's protective wax coating. In case children pick one up or they fall from trees onto unsuspecting folks below, it's important to remember the caterpillars aren't harmful to humans, unless there is an allergy to the critters' hairs. Mostly, they're just annoying and gross.


Globe and Mail
an hour ago
- Globe and Mail
3 Best Growth Stocks to Buy Now, 6/6/2025, According to Analysts
Growth stocks represent companies poised for rapid expansion, beating both the overall market and industry peers. This growth potential translates to large capital appreciation for investors. Also, investing in growth stocks can be a long-term strategy, as these companies reinvest profits to drive future expansion. Confident Investing Starts Here: One way to identify these stocks is through their past revenue or earnings growth. Today, we have shortlisted stocks whose revenue has grown at a five-year CAGR of more than 5%. Along with this parameter, we have zeroed in on stocks that have received Strong Buy ratings from Wall Street analysts. Here are this week's stocks: DraftKings (DKNG) – This company provides digital sports entertainment and gaming services. Its average price target of $54.43 implies a 57.22% upside potential from the current levels. The company's revenue has grown at a five-year CAGR of nearly 51%. ServiceNow (NOW) – ServiceNow provides cloud computing solutions that automate enterprise IT operations. NOW stock's average price target of $1,064.33 implies an upside potential of 4.16%. Its revenue increased at a CAGR of over 19% in the past five years. Uber Technologies (UBER) – This transportation company offers ride-hailing, courier services, and food delivery services. The stock has a price forecast of $98.61, which implies a 14.9% upside potential. UBER's revenues have witnessed a 31.6% five-year CAGR. What Is Tipranks' Smart Growth Newsletter? TipRanks' Smart Growth Newsletter provides top growth investment ideas on a weekly basis, based on TipRanks' data and analysis. The newsletter includes macro-economic, market-wide, and company-specific analysis to help investors understand the trends that may influence their growth investments. Stay ahead of the market – subscribe now!


Globe and Mail
an hour ago
- Globe and Mail
Why an Investment in This Index Can Be the Best Gift You Give New Grads This Year
May and June are graduation season, and if you haven't decided what to get for the new grad in your life, you may want to consider gifting them an investment. It may not be as flashy as a car or trip abroad, but that investment is likely to grow over time. In the process, it can not only underscore just how valuable investing can be but also how simple it can be as well. Beginners often believe successfully investing in the stock market must be a complex undertaking that requires years of experience and countless hours of research. But picking a good investment can be much easier than that. Tracking a broad market index such as the S&P 500 (SNPINDEX: ^GSPC) is arguably the simplest way for anyone to get started, and your gift can put the new grad you know on the right path. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Why an investment in the S&P 500 makes sense for new grads The biggest advantage young investors have is time. The problem is that many students and young professional aren't thinking about saving for retirement. Even if they are, they're often financially unable to do so as they grapple with student debt, rent payments, and other adult responsibilities. Or worse, they're most interested in finding the next big growth stock or chasing meme stocks. Investing in the safe and dependable S&P 500 probably doesn't rank too highly in any of these scenarios. But with decades ahead of them, new grads will benefit immensely from the effects of compounding. The S&P 500 has grown an average of 10% per year in its history, enough to mint a sizable nest egg for patient investors (more on this below). And beyond this attractive rate of return, the index is made up of 500 of the largest U.S. companies with exposure to all of the major sectors, industries, and geographic markets. Here's how much your gift could grow over time Though I've been talking about the benefits of investing in the S&P 500, you can't just buy a piece of the index. Instead, you can invest in an exchange-traded fund (ETF) that tracks it and offers very similar returns. A popular option is the SPDR S&P 500 ETF (NYSEMKT: SPY). This low-cost fund has an expense ratio of just 0.0945%, so for every $1,000 you have invested in the ETF, you lose less than $1 per year to management fees. When investing over the long term, high expense ratios can add up to hundreds and thousands of dollars. Over the past decade, the SPDR S&P 500 ETF has grown more than 180%. Including dividends, its total return climbs above 230%. Data by YCharts. That works out to a compound annual growth rate (CAGR) of 12.7% over the past 10 years, which is higher than the S&P 500's historical average. But taking a slightly more conservative approach and assuming the index and ETF will deliver a 10% annual return long term, here's how different sized gifts -- all invested in the SPDR S&P 500 ETF -- could grow for a new grad: Gift Amount 20 Years 30 Years 40 Years 50 Years $100 $673 $1,745 $4,526 $11,739 $200 $1,345 $3,490 $9,052 $23,478 $500 $3,364 $8,725 $22,630 $58,695 $1,000 $6,727 $17,449 $45,259 $117,391 $2,000 $13,455 $34,899 $90,519 $234,782 $3,000 $20,182 $52,348 $135,778 $352,173 Table and calculations by author. Your gift could become a five or even six-figure sum if its recipient is patient enough to let compounding do its magic. Though inflation will diminish the purchasing power of the estimates above, this is still a great example of how a simple investment in the stock market can become a major windfall for young grads, even if retirement planning is the last thing on their minds. Should you invest $1,000 in SPDR S&P 500 ETF Trust right now? Before you buy stock in SPDR S&P 500 ETF Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SPDR S&P 500 ETF Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to171%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025